AdvanSix Inc. (ASIX) SEC Filings & Earnings Calls
EquiReason read 12 AdvanSix Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-08-17 — AdvanSix refinanced its credit facility: paid off existing loans, terminated prior credit agreement, and entered a new Credit Agreement with Citizens Bank as administrative agent. .
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 424.2M
- P/E TTM
- —
- Dividend yield
- 4.1%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
17 Aug 20268-K · 1.01, 1.02, 2.03AdvanSix refinanced its credit facility: paid off existing loans, terminated prior credit agreement, and entered a new Credit Agreement with Citizens Bank as administrative agent. No financial terms disclosed.open
Risks flagged
New debt obligations increase financial leverage.
“Entry into new credit agreement.”
7 Aug 20268-K · 2.02, 8.01Sales $421M (+3% y/y); Net Income $3M (-90% y/y); Adjusted EBITDA $32M (-43% y/y); Guidance: Capex $75-$95M; plant turnaround impact ~$17M; expect 2H cash flow improvementearningsopen
Figures in the filing · each found in the filing text
| Sales · Q2-2026 | $421M | +3% y/y |
| Net Income · Q2-2026 | $3M | -90% y/y |
| Adjusted EBITDA · Q2-2026 | $32M | -43% y/y |
| Cash Flow from Operations · Q2-2026 | $10M | -52% y/y |
| Capital Expenditures · Q2-2026 | $21M | -27% y/y |
| Free Cash Flow · Q2-2026 | $-11M | |
| Diluted Earnings Per Share · Q2-2026 | $0.12 | -90% y/y |
| Adjusted Diluted Earnings Per Share · Q2-2026 | $0.19 | -85% y/y |
| Adjusted EBITDA Margin · Q2-2026 | 7.6% |
Guidance
Capex $75-$95M; plant turnaround impact ~$17M; expect 2H cash flow improvement
Guidance implies continued pressure: sequential pricing decline in ammonium sulfate, subdued industrial demand, but capex reduction and 2H cash flow improvement expected. No explicit revenue or earnings guidance provided.
Risks flagged
Significant volume decline of 15% driven by weak agricultural fundamentals and farmer profitability challenges.
“Sales volume in the quarter fell short of expectations due to a decline in ammonium sulfate as the spring planting season was challenged by farmer profitability and resulting fertilizer consumption overall.” · word for word
Adjusted EBITDA margin compressed by 600 bps to 7.6% due to lower volumes and raw material cost inflation.
“Adjusted EBITDA Margin % 7.6% vs 13.6% prior year, down 600 bps.”
Higher effective tax rate due to non-recurrence of 45Q carbon capture tax credits.
“higher effective tax rate driven primarily by 45Q carbon capture tax credits claimed in the prior year period.” · word for word
Negative free cash flow of -$10.7M; expect improvement in 2H.
“Free Cash Flow (10,676) vs (7,155) prior year.”
7 Aug 202610-QNet income decrease $-67M; Operating cash flow $-5M; Revolver balance $275M; Guidance: Capex guidance $75M-$95M for FY2026open
Figures in the filing · each found in the filing text
| Net income decrease · H1-2026 | $-67M | |
| Operating cash flow · H1-2026 | $-5M | |
| Revolver balance · 2026-06-30 | $275M |
Guidance
Capex guidance $75M-$95M for FY2026
Capex guidance maintained; no revenue or earnings guidance provided; margin pressure evident from net income decline.
Risks flagged
Earnings deterioration
“a $67.0 million decrease in Net income” · word for word
Liquidity pressure
“Cash provided by operating activities decreased by $37.8 million ... to $(5,294)” · word for word
8 May 202610-QNet income decrease $-39M; Operating cash flow $-15M; Revolver balance $270M; Guidance: Capex guidance $75M-$95M for FY2026open
Figures in the filing · each found in the filing text
| Net income decrease · Q1-2026 | $-39M | |
| Operating cash flow · Q1-2026 | $-15M | |
| Revolver balance · 2026-03-31 | $270M |
Guidance
Capex guidance $75M-$95M for FY2026
Capex guidance maintained; no revenue or earnings guidance provided; margin pressure evident from net income decline.
Risks flagged
Earnings deterioration
“a $38.9 million decrease in Net income” · word for word
Liquidity pressure
“Cash provided by operating activities decreased by $26.8 million ... to $(15,332)” · word for word
8 May 20268-K · 2.02, 8.01Sales $404M (+7% y/y); Net Income (loss) $-16M; Diluted Earnings Per Share $-0.58; Guidance: Capex $75-95M; turnaround impact $17-22Mearningsopen
Figures in the filing · each found in the filing text
| Sales · Q1-2026 | $404M | +7% y/y |
| Net Income (loss) · Q1-2026 | $-16M | |
| Diluted Earnings Per Share · Q1-2026 | $-0.58 | |
| Adjusted Diluted Earnings Per Share · Q1-2026 | $-0.50 | |
| Adjusted EBITDA · Q1-2026 | $5M | -91% y/y |
| Cash Flow from Operations · Q1-2026 | $-15M | |
| Capital Expenditures · Q1-2026 | $36M | +6% y/y |
| Free Cash Flow · Q1-2026 | $-51M | |
| Nylon Sales · Nylon · Q1-2026 | $88M | +0% y/y |
| Caprolactam Sales · Caprolactam · Q1-2026 | $68M | +1% y/y |
Guidance
Capex $75-95M; turnaround impact $17-22M
Management reaffirmed outlook with balanced supply/demand in planting season; expects sequential improvement in Q2; capex decreasing YoY
Risks flagged
Significant margin compression due to higher sulfur and natural gas costs, winter storm impact, and absence of prior year insurance proceeds
“Adjusted EBITDA of $4.8 million in the quarter decreased $46.9 million versus the prior year primarily driven by the absence of $26 million of prior year insurance proceeds, the unfavorable impact of higher sulfur and natural gas raw material prices, and higher plant costs primarily driven by utilities costs and $11 million of winter storm impact” · word for word
Negative free cash flow of -$51M in the quarter
“Free Cash Flow (51,268) (22,619)”
29 Apr 2026DEF 14ASales $1.52B (+0% y/y); Net Income $49M (+12% y/y); Adjusted EBITDA $157M (+10% y/y)open
Figures in the filing · each found in the filing text
| Sales · FY2025 | $1.52B | 0% y/y |
| Net Income · FY2025 | $49M | +12% y/y |
| Adjusted EBITDA · FY2025 | $157M | +10% y/y |
| Free Cash Flow · FY2025 | $6M | +279% y/y |
| Capital Expenditures · FY2025 | $116M | -13% y/y |
| Cash Flow from Operations · FY2025 | $123M | -9% y/y |
| Adjusted EBITDA Margin · FY2025 | 10.3% | |
| Adjusted EPS (Diluted) · FY2025 | $2.28 | +16% y/y |
| Nylon Sales · Nylon · FY2025 | $310M | -11% y/y |
| Plant Nutrients Sales · Plant Nutrients · FY2025 | $564M | +23% y/y |
Risks flagged
Cyclical Downturn Risk
“2025 was a year characterized by continued cyclical trough market conditions for Nylon Solutions” · word for word
Input Cost Inflation Risk
“robust Plant Nutrients supply and demand fundamentals amid an increasing input cost environment” · word for word
Customer Concentration Risk
“In 2025, our 10 largest customers accounted for approximately 40% of our total sales across all product lines.”
13 Apr 20268-K · 5.02Reported the departure of a director or principal officer (CEO/CFO change); filed financial statements and exhibits with this reportopen
Risks flagged
Leadership transition risk is low as the new CFO has relevant experience and the interim CFO returns to prior role.
“No material risks identified; transition appears orderly with experienced executive.”
20 Feb 20268-K · 2.02, 8.01Sales $360M (+9% y/y); Net Income (loss) $-3M; Adjusted EBITDA $25M (+142% y/y)earningsopen
Figures in the filing · each found in the filing text
| Sales · Q4-2025 | $360M | +9% y/y |
| Net Income (loss) · Q4-2025 | $-3M | |
| Adjusted EBITDA · Q4-2025 | $25M | +142% y/y |
| Adjusted EBITDA Margin % · Q4-2025 | 6.9% | |
| Cash Flow from Operations · Q4-2025 | $64M | -1% y/y |
| Capital Expenditures · Q4-2025 | $28M | -20% y/y |
| Free Cash Flow · Q4-2025 | $36M | +21% y/y |
| Sales · FY-2025 | $1.52B | +0% y/y |
| Net Income · FY-2025 | $49M | +12% y/y |
| Adjusted EBITDA · FY-2025 | $157M | +10% y/y |
Risks flagged
Cyclical trough in Nylon Solutions and mixed Chemical Intermediates conditions pose ongoing risk.
“Continued cyclical trough market conditions for Nylon Solutions, mixed Chemical Intermediates industry conditions with lower net pricing as anticipated.” · word for word
7 Nov 202510-QAdvanSix reported 9M 2025 operating cash flow of $59.1M, down $12.1M YoY, with increased borrowing and maintained capex guidance of $120M-$125M.earningsopen
Figures in the filing · each found in the filing text
| Operating Cash Flow · 9M-2025 | $59M | -17% y/y |
| Capital Expenditures (cash paid) · 9M-2025 | $89M | |
| Total Debt · 2025-09-30 | $250M | |
| Dividend per Share · Q3-2025 | $0.16 |
Guidance
Capital expenditures expected $120M-$125M for 2025
Capex guidance reaffirmed at $120M-$125M for 2025.
Risks flagged
No material changes to risk factors
“There have been no material changes to our risk factors as previously disclosed in” · word for word
7 Nov 20258-K · 2.02, 8.01Sales $374M (-6% y/y); Net Income (Loss) $-3M; Diluted Earnings Per Share $-0.10; Guidance: Capex guidance reduced to $120-125M from prior; no revenue guidanceearningsopen
Figures in the filing · each found in the filing text
| Sales · Q3-2025 | $374M | -6% y/y |
| Net Income (Loss) · Q3-2025 | $-3M | |
| Diluted Earnings Per Share · Q3-2025 | $-0.10 | |
| Adjusted Diluted Earnings Per Share · Q3-2025 | $0.08 | -91% y/y |
| Adjusted EBITDA · Q3-2025 | $25M | -54% y/y |
| Cash Flow from Operations · Q3-2025 | $27M | -54% y/y |
| Capital Expenditures · Q3-2025 | $27M | -13% y/y |
| Free Cash Flow · Q3-2025 | $66000.00 | -100% y/y |
Guidance
Capex guidance reduced to $120-125M from prior; no revenue guidance
Capex cut to conserve cash; navigating extended nylon downturn; Plant Nutrients strength partially offsetting.
Risks flagged
Extended downturn in nylon cycle and weak chemical intermediates pricing pressuring margins.
“Navigating an extended downturn in the nylon cycle; Chemical Intermediates pricing decline.” · word for word
Cash flow deterioration; free cash flow nearly zero.
“Free cash flow $66K vs $26.8M prior year.”
AdvanSix Inc. — questions
- What did AdvanSix Inc. file recently?
- 12 SEC filings in the last 12 months. Latest: 8-K on 2026-08-17 — AdvanSix refinanced its credit facility: paid off existing loans, terminated prior credit agreement, and entered a new Credit Agreement with Citizens Bank as administrative agent. No financial terms disclosed.
Every figure on this page comes from AdvanSix Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.